Adobe

STAT+ | Syndax wins U.S. approval for leukemia treatment

This genetic type of leukemia is present in approximately 10% of cases, and leads to high relapse rates and survival of less than a year

By Adam Feuerstein

With rising cancer rates in younger adults, experts emphasize better tests

Despite recommendations for screening at younger ages, colonoscopies and mammograms are still “vastly underutilized,” experts say. 

By Anil Oza

STAT+ | Pharma still ‘falling short’ in providing access to low- and middle-income countries, analysis finds

A new analysis found the few companies with programs for improving access in poor countries largely fail to report how many patients are being reached.

By Ed Silverman